Survey of Physicians' Attitudes to the Haemophilus Influenzae Type-b Vaccine

Area of Science:

• Public Health and Preventative Medicine
• Pediatric Immunization Programs

Background:

• Haemophilus influenzae type b (Hib) infections pose a significant health risk, particularly to young children.
• The implementation of a recommended Hib vaccine program in Canada aimed to reduce disease incidence.

Purpose of the Study:

• To assess Canadian physicians' attitudes towards the recommended Haemophilus influenzae type b vaccine program.
• To identify barriers and facilitators influencing vaccine recommendation and uptake.

Main Methods:

• A national survey was conducted across nine Canadian centers.
• Questionnaires were distributed to 448 family physicians and 315 pediatricians.
• Response rates were 42% for family physicians and 64% for pediatricians.

Main Results:

• Only 42% of family physicians and 57% of pediatricians intended to recommend the Hib vaccine to all eligible patients.
• Physicians highlighted the need for single-dose vials, government funding for accessibility, and a vaccine suitable for children under 24 months.
• Public health education was also identified as crucial for program success.

Conclusions:

• Physician acceptance and recommendation of the Haemophilus influenzae type b vaccine are contingent upon addressing key logistical, financial, and product-related concerns.
• Effective implementation of the Hib immunization program requires government support, improved vaccine packaging, and targeted public health initiatives.